These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22138849)

  • 1. A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Support Care Cancer; 2012 Oct; 20(10):2295-304. PubMed ID: 22138849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Pediatr Infect Dis J; 2012 Apr; 31(4):353-8. PubMed ID: 22173145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
    Paul M; Yahav D; Fraser A; Leibovici L
    J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials.
    Sung L; Manji A; Beyene J; Dupuis LL; Alexander S; Phillips R; Lehrnbecher T
    Pediatr Infect Dis J; 2012 May; 31(5):431-5. PubMed ID: 22189521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
    Tang X; Chen L; Li Y; Jiang J; Li X; Liang X
    Medicine (Baltimore); 2020 Oct; 99(43):e22725. PubMed ID: 33120768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
    Cometta A; Glauser MP
    J Chemother; 1996 Oct; 8(5):375-81. PubMed ID: 8957718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.
    Manji A; Beyene J; Dupuis LL; Phillips R; Lehrnbecher T; Sung L
    Support Care Cancer; 2012 Jun; 20(6):1135-45. PubMed ID: 22402749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
    Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
    J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.
    Demir HA; Kutluk T; Ceyhan M; Yağcı-Küpeli B; Akyüz C; Cengiz B; Varan A; Kara A; Yalçın B; Seçmeer G; Büyükpamukçu M
    Pediatr Hematol Oncol; 2011 May; 28(4):299-310. PubMed ID: 21413829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
    Paul M; Soares-Weiser K; Leibovici L
    BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
    Matsuoka H; Tsukamoto A; Shirahashi A; Koga S; Suzushima H; Shibata K; Uozumi K; Yamashita K; Okamura S; Kawano F; Tamura K;
    Leuk Lymphoma; 2006 Aug; 47(8):1618-23. PubMed ID: 16966275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review.
    Torfoss D; Høiby EA; Holte H; Kvaløy S
    Acta Oncol; 2012 Apr; 51(4):433-40. PubMed ID: 22175253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the options for risk-based therapy in febrile neutropenia.
    Rolston KV
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):411-6. PubMed ID: 9635917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.